$173.34
0.78% day before yesterday
NYSE, May 30, 10:10 pm CET
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Stock price

$173.34
-4.88 2.74% 1M
+11.83 7.32% 6M
+22.48 14.90% YTD
+34.01 24.41% 1Y
+27.95 19.22% 3Y
+54.90 46.35% 5Y
+97.86 129.65% 10Y
NYSE, Closing price Fri, May 30 2025
+1.34 0.78%
ISIN
US74834L1008
Symbol
DGX
Sector

Key metrics

Market capitalization $19.35b
Enterprise Value $25.02b
P/E (TTM) P/E ratio 21.97
EV/FCF (TTM) EV/FCF 23.70
EV/Sales (TTM) EV/Sales 2.46
P/S ratio (TTM) P/S ratio 1.91
P/B ratio (TTM) P/B ratio 2.80
Dividend yield 1.73%
Last dividend (FY24) $3.00
Revenue growth (TTM) Revenue growth 9.38%
Revenue (TTM) Revenue $10.16b
EBIT (operating result TTM) EBIT $1.46b
Free Cash Flow (TTM) Free Cash Flow $1.06b
Cash position $188.00m
EPS (TTM) EPS $7.89
P/E forward 19.96
P/S forward 1.79
EV/Sales forward 2.32
Short interest 3.99%
Show more

Is Quest Diagnostics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Quest Diagnostics Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Quest Diagnostics forecast:

10x Buy
48%
10x Hold
48%
1x Sell
5%

Analyst Opinions

21 Analysts have issued a Quest Diagnostics forecast:

Buy
48%
Hold
48%
Sell
5%

Financial data from Quest Diagnostics

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
10,158 10,158
9% 9%
100%
- Direct Costs 6,791 6,791
9% 9%
67%
3,367 3,367
10% 10%
33%
- Selling and Administrative Expenses 1,765 1,765
8% 8%
17%
- Research and Development Expense - -
-
-
1,595 1,595
12% 12%
16%
- Depreciation and Amortization 137 137
23% 23%
1%
EBIT (Operating Income) EBIT 1,458 1,458
11% 11%
14%
Net Profit 892 892
6% 6%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Quest Diagnostics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Quest Diagnostics Stock News

Neutral
PRNewsWire
12 days ago
Quest's second "Know Your Health" survey explores Americans' perceptions and priorities on their well-being in 2025 Nearly one-third of Americans say their doctors/HCPs do not take the time to discuss preventive care and wellness with them; More than half of millennials, Gen Z cite barriers to accessing medical care SECAUCUS, N.J. , May 20, 2025 /PRNewswire/ -- questhealth.com, the consumer-ini...
Neutral
PRNewsWire
16 days ago
SECAUCUS, N.J. , May 16, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a presentation at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2...
Neutral
PRNewsWire
18 days ago
SECAUCUS, N.J. , May 14, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.80 per share, payable on July 21, 2025 to shareholders of record of Quest Diagnostics common stock on July 7, 2025.
More Quest Diagnostics News

Company Profile

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Head office United States
CEO James Davis
Employees 50,500
Founded 1967
Website www.questdiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today